000281855 001__ 281855
000281855 005__ 20251118102958.0
000281855 0247_ $$2doi$$a10.1186/s42466-025-00446-4
000281855 0247_ $$2pmid$$apmid:41189028
000281855 037__ $$aDZNE-2025-01228
000281855 041__ $$aEnglish
000281855 082__ $$a610
000281855 1001_ $$0P:(DE-2719)9001452$$avon Rennenberg, Regina$$b0$$eFirst author
000281855 245__ $$aCognitive performance in patients with ischemic stroke and additional myocardial injury - results from the multicenter prospective observational PRAISE study.
000281855 260__ $$a[London]$$bBioMed Central$$c2025
000281855 3367_ $$2DRIVER$$aarticle
000281855 3367_ $$2DataCite$$aOutput Types/Journal article
000281855 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1763372374_17165
000281855 3367_ $$2BibTeX$$aARTICLE
000281855 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000281855 3367_ $$00$$2EndNote$$aJournal Article
000281855 520__ $$aIn the general population, cognitive impairment and dementia are more common in individuals with prior myocardial injury, defined as elevated levels of high-sensitive cardiac troponin (hs-cTn). In stroke patients, data on the link between myocardial injury and cognitive outcome are scarce. We aimed to analyze the association between the severity of myocardial injury (degree of hs-cTn elevation), presence of acute myocardial injury (dynamic change in elevated hs-cTn values > 20% in serial measurements) and cognitive performance over time after acute ischemic stroke.This is a prespecified analysis of the prospective multicenter observational PRediction of Acute coronary syndrome in acute Ischemic StrokE (PRAISE) study. PRAISE included 254 patients with an acute ischemic stroke or transient ischemic attack (TIA) and myocardial injury in 26 centers in Germany. Patients underwent cognitive assessment at baseline and before hospital discharge using the Montreal Cognitive Assessment (MoCA) and at three and twelve months after the index event using the Telephone Interview for Cognitive Status (TICS). We used linear regression to analyze the associations between cognitive performance and (1) severity of myocardial injury and (2) presence of acute myocardial injury. The association between hs-cTn and TICS scores over time was examined using inverse probability weighted generalized linear models.Severity of myocardial Injury was associated with lower MoCA scores (adjusted beta - 2.6, 95% CI -4.0 - -1.2, p < 0.001) and higher proportion of cognitive impairment (i.e. MoCA score < 26 points) (adjusted OR 2.9, 95%CI 1.3-6.7, p = 0.012). Acute myocardial injury was associated with better cognitive performance (adjusted beta 1.8, 95% CI 0.4-3.1, p = 0.011). We found no association between hs-cTn and cognitive decline over twelve months.In patients with ischemic stroke, the severity of myocardial injury in general but not the presence of acute myocardial injury at time of stroke is associated with cognitive impairment.Clinicaltrials.gov NCT03609385 https://clinicaltrials.gov/study/NCT03609385?term=NCT03609385&rank=1 Date of registration 6th July 2018.
000281855 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000281855 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000281855 7001_ $$0P:(DE-2719)9001453$$aLitmeier, Simon$$b1$$udzne
000281855 7001_ $$aSzabo, Kristina$$b2
000281855 7001_ $$0P:(DE-2719)9003061$$aMengel, Annerose$$b3$$udzne
000281855 7001_ $$aPetersen, Martina$$b4
000281855 7001_ $$aWunderlich, Silke$$b5
000281855 7001_ $$aMichalski, Dominik$$b6
000281855 7001_ $$aThomalla, Götz$$b7
000281855 7001_ $$aKallmünzer, Bernd$$b8
000281855 7001_ $$0P:(DE-2719)2810273$$aPetzold, Gabor$$b9$$udzne
000281855 7001_ $$0P:(DE-2719)2000030$$aDichgans, Martin$$b10$$udzne
000281855 7001_ $$aSiepmann, Timo$$b11
000281855 7001_ $$aRoyl, Georg$$b12
000281855 7001_ $$aRingleb, Peter Arthur$$b13
000281855 7001_ $$0P:(DE-2719)9000234$$aNolte, Christian H$$b14
000281855 7001_ $$0P:(DE-2719)2811033$$aEndres, Matthias$$b15$$eLast author$$udzne
000281855 773__ $$0PERI:(DE-600)2947493-0$$a10.1186/s42466-025-00446-4$$gVol. 7, no. 1, p. 84$$n1$$p84$$tNeurological research and practice$$v7$$x2524-3489$$y2025
000281855 8564_ $$uhttps://pub.dzne.de/record/281855/files/DZNE-2025-01228%20SUP.docx
000281855 8564_ $$uhttps://pub.dzne.de/record/281855/files/DZNE-2025-01228.pdf$$yOpenAccess
000281855 8564_ $$uhttps://pub.dzne.de/record/281855/files/DZNE-2025-01228%20SUP.doc
000281855 8564_ $$uhttps://pub.dzne.de/record/281855/files/DZNE-2025-01228%20SUP.odt
000281855 8564_ $$uhttps://pub.dzne.de/record/281855/files/DZNE-2025-01228%20SUP.pdf
000281855 8564_ $$uhttps://pub.dzne.de/record/281855/files/DZNE-2025-01228.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000281855 909CO $$ooai:pub.dzne.de:281855$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000281855 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001452$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000281855 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9001453$$aExternal Institute$$b1$$kExtern
000281855 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9003061$$aExternal Institute$$b3$$kExtern
000281855 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810273$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b9$$kDZNE
000281855 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2000030$$aExternal Institute$$b10$$kExtern
000281855 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811033$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b15$$kDZNE
000281855 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000281855 9141_ $$y2025
000281855 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-30
000281855 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000281855 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2024-12-30
000281855 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:42:53Z
000281855 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:42:53Z
000281855 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-30
000281855 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-30
000281855 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000281855 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-04-10T15:42:53Z
000281855 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-30
000281855 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-30
000281855 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-30
000281855 9201_ $$0I:(DE-2719)1811005$$kAG Endres$$lInterdisciplinary Dementia Research$$x0
000281855 9201_ $$0I:(DE-2719)1013020$$kAG Petzold$$lVascular Neurology$$x1
000281855 980__ $$ajournal
000281855 980__ $$aVDB
000281855 980__ $$aUNRESTRICTED
000281855 980__ $$aI:(DE-2719)1811005
000281855 980__ $$aI:(DE-2719)1013020
000281855 9801_ $$aFullTexts